Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer.

Gynecologic oncology - 1 Feb 2024

Penvose Katherine N, Reed Shelby D, Sepulveda Juan Marcos Gonzalez, Mastylak Alicja, Scott Amelia, Hayes Taylor, Shank Juliana, Havrilesky Laura J

Abstract excerpt

OBJECTIVE: In this study, we aimed to develop education to assist BRCA mutation carriers in making informed decisions about HRT in the context of risk-reducing surgery, while simultaneously clarifying their treatment-specific values and reducing decisional conflict. METHODS: We enrolled premenopausal BRCA mutation carriers ages 19-49 without prior cancer or risk-reducing salpingo-oophorectomy to structured...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Hormone Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastectomy

Share to Osteoporosis

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Pilot Projects

Share to Thrombosis

Source

Identifiers

PMID: 38150837
DOI: 10.1016/j.ygyno.2023.11.022

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and testing of patient-centered education about hormone replacement therapy for women at high genetic risk of breast and ovarian cancer.PMID 38150837Read ↗

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.Semantic proximity Read ↗

BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians' recommendations.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Helping Patients Understand and Cope with BRCA Mutations.Semantic proximity Read ↗

Counselling of path_BRCA carriers who are considering risk-reducing oophorectomy.Semantic proximity Read ↗

The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication.Semantic proximity Read ↗

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.Semantic proximity Read ↗

A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.Semantic proximity Read ↗

Cancer risk management decision making for BRCA+ women.Semantic proximity Read ↗

Risk-reduction surgery decisions in high-risk women seen for genetic counseling.Semantic proximity Read ↗

Psychosexual responses to BRCA gene mutations in women of childbearing age.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.